DrugPatentWatch Week in Review
Patent Expirations and Generic Competition This week saw several major blockbuster drugs facing patent expirations, potentially opening the market for […]
DrugPatentWatch Week in Review Read Post »
Patent Expirations and Generic Competition This week saw several major blockbuster drugs facing patent expirations, potentially opening the market for […]
DrugPatentWatch Week in Review Read Post »
Annual Drug Patent Expirations for MOVANTIK Movantik is a drug marketed by Valinor and is included in one NDA. It
New patent expiration for Valinor drug MOVANTIK Read Post »
Introduction Patent portfolios are critical assets for pharmaceutical companies, providing market exclusivity and protecting revenue streams for drug products. Effective
Best Practices for Drug Patent Portfolio Management Read Post »
This is an example from the DrugPatentWatch AI Research Assistant, which is available with DrugPatentWatch subscriptions. The DrugPatentWatch AI Research
What is the market forecast for Ozempic? Read Post »
Introduction In the rapidly evolving landscape of pharmaceutical patent disputes in China, injunctive relief has emerged as a critical tool
The Double-Edged Sword: Opportunities and Challenges in China’s Patent Litigation System Read Post »
DrugChatter is an innovative AI-powered search and answer engine designed to revolutionize how we access and comprehend information. Harnessing the
Introducing DrugChatter: Revolutionizing Information Access Read Post »
Introduction: The United States Patent and Trademark Office (USPTO) has recently released a comprehensive study on drug patents and exclusivity
The 505(b)(2) regulatory pathway provides an attractive avenue for drug developers to bring new products to market by leveraging existing
Leveraging 505(b)(2) to Innovate Beyond Existing Drug Patents Read Post »
MOVANTIK (naloxegol oxalate) Valinor Patent: 7,056,500 Expiration: Jun 29, 2024 See More … For more information on how DrugPatentWatch can
Drug Patent Expirations for the Week of June 23, 2024 Read Post »
Get fresh news and insights, drug patent expirations & more…